Unknown OBSERVATIONAL NCT03114826

Study of the Impact of VEGF Polymorphism on the Development of Renal Carcinoma in Renal Transplant Patients (VE-CART)

Sponsor: Centre Hospitalier Universitaire, Amiens

Conditions Polymorphism Renal Carcinoma Renal Transplantation VEGF

Interventions To study the polymorphism of the gene encoding VEGF (rs699947) as a predictive marker

Updated 7 times since 2017 Last updated: Apr 10, 2017 Started: Oct 6, 2016 Primary completion: Oct 5, 2019 Completion: Oct 5, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Polymorphism and Renal Carcinoma, this trial is ongoing. The trial is conducted by Centre Hospitalier Universitaire, Amiens and has accumulated 7 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Nov 2019 — Jan 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jun 2018 — Nov 2019 [monthly]

Recruiting

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
May 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Universitaire, Amiens

Data source: Centre Hospitalier Universitaire, Amiens

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Amiens, France